Abstract:1. Introduction 310 2. Protein-only hypothesis 312 3. The scrapie prion protein PrP Sc 313 3.1 Purification of PrP 27–30 313 3.2 Proteinase K resistance 314 3.3 Scrapie-associated fibrils 314 3.4 Smallest infectious unit 316 3.5 Conformational properties 316 3.6 Dissociation and stability 319 4. The cellular prion protein PrP C 321 4.1 Prnp expression 321 4.2 Biosynthetic pathway 322 4.3 NMR structures 324 4.4 Copper binding 326 5. Post-translational PrP conversion 327 5.1 Conformational isoforms 327 5.2 Location of propagation 329 5.3 Minimal PrP sequence 330 5.4 Prion species barrier 331 5.5 Prion strains 332 6. Effect of familial TSE mutations 333 6.1 Thermodynamic stability of PrP C 334 6.2 De novo synthesis of PrP Sc 335 6.3 Transmembrane PrP forms 337 7. Physical properties of synthetic PrP 337 7.1 Amyloidogenic peptides 337 7.2 Folding intermediates 339 8. Hypothetical protein X 340 8.1 Two species-specific epitopes 340 8.2 Mapping the protein X epitope 341 9. Chaperone-mediated PrP conversion 343 9.1 Hsp60 and Hsp10 chaperonins 343 9.2 GroEL promoted PrP-res formation 345 9.3 Membrane-associated chaperonins 345 9.4 Preference of GroEL for positive charges 347 9.5 Potential GroEL/Hsp60 epitopes on PrP 347 9.6 Conformations of chaperonin-bound PrP 349 9.7 Conserved Hsp60 substrate binding sites 349 9.8 Requirement of ATP-hydrolysis 351 9.9 Hsp60-mediated prion propagation 354 10. Template-assisted annealing model 355 11. Acknowledgments 357 12. References 357 Although the central paradigm of protein folding (Anfinsen, 1973), that the unique three-dimensional structure of a protein is encoded in its amino acid sequence, is well established, its generality has been questioned due to two recent developments in molecular biology, the ‘prion’ and ‘molecular chaperone’. Biochemical characterization of infectious scrapie material causing central nervous system (CNS) degeneration indicates that the necessary component for disease propagation is proteinaceous (Prusiner, 1982), as first outlined by Griffith (1967) in general terms, and involves a conversion from a cellular prion protein, denoted PrP C , into a toxic scrapie form, PrP Sc , which is facilitated by PrP Sc acting as a template for PrP C to form new PrP Sc molecules (Prusiner, 1987). The ‘protein-only’ hypothesis implies that the same polypeptide sequence, in the absence of any post-translational modifications, can adopt two considerably different stable protein conformations (Fig. 1). Thus, in the case of prions it is possible, although not proven, that they violate the central paradigm of protein folding. There is some indirect evidence that another factor, provisionally named ‘protein X’, might be involved in the conformational conversion process (Prusiner et al . 1998), which includes a dramatic change from α-helical into β-sheet secondary structure (Fig. 1). This factor has not been identified yet, but it has been proposed that protein X may act as a molecular chaperone. The idea that molecular chaperones play a critical role in the generation of PrP Sc is appealing also from a theoretical point of view, because PrP Sc formation involves changes in protein folding and possibly intermolecular aggregation (Fig. 1), processes in which chaperones are known to participate (Musgrove & Ellis, 1986). The discovery and functional analysis of more than a dozen molecular chaperones made it clear that these proteins do not complement folding information that is not already contained in the genetic code (Ellis et al . 1989); rather they facilitate the folding and assembly of proteins by preventing misfolding and refolding misfolded proteins (Hartl, 1996). Whether a molecular chaperone or another type of macromolecule is identified as the conversion factor, therefore, the molecular chaperone concept is likely to contribute to the understanding of the molecular nature of PrP C to PrP Sc conversion. In this review I consider the prion concept from the view of a structural biologist whose main interest focuses on spontaneous and chaperone-mediated conformational changes in proteins.

Grp78 destabilization of infectious prions is strain-specific and modified by multiple factors including accessory chaperones and pH

Heat Shock Protein 70 Selectively Mediates the Degradation of Cytosolic PrPs and Restores the Cytosolic PrP-induced Cytotoxicity Via a Molecular Interaction

Regulated Proteolysis Induces Aberrant Phase Transition of Biomolecular Condensates into Aggregates: A Protective Role for the Chaperone Clusterin

Effects of the Pathogenic Mutation A117V and the Protective Mutation H111S on the Folding and Aggregation of PrP106-126: Insights from Replica Exchange Molecular Dynamics Simulations.

Protein Disulfide Isomerase Regulates Endoplasmic Reticulum Stress and the Apoptotic Process During Prion Infection and Prp Mutant-Induced Cytotoxicity

Comparison of the Unfolding and Oligomerization of Human Prion Protein under Acidic and Neutral Environments by Molecular Dynamics Simulations

Interaction Between 14-3-3β and PrP Influences the Dimerization of 14-3-3 and Fibrillization of PrP106-126.

Influence of guanidine on proteinase K resistance in vitro and infectivity of scrapie prion protein PRPSc

N-terminal Prion Protein Peptides (prp(120–144)) Form Parallel In-Register Β-Sheets Via Multiple Nucleation-Dependent Pathways.

Ubiquitin Ligase Gp78 Targets Unglycosylated Prion Protein PrP for Ubiquitylation and Degradation.

Ph-Induced Misfolding Mechanism of Prion Protein: Insights from Microsecond-Accelerated Molecular Dynamics Simulations

Selective neuronal targeting in prion disease

Regulation of proteasomes in prion disease.

Preventing misfolding of the prion protein by trimethylamine N-oxide

Distinct Effects of Mutations on Biophysical Properties of Human Prion Protein Monomers and Oligomers.

The Positively Charged Cluster in the N-terminal Disordered Region may Affect Prion Protein Misfolding: Cryo-EM Structure of Hamster PrP(23–144) Fibrils

Chaperone-mediated heterotypic phase separation prevents the amyloid formation of the pathological Y145Stop variant of the prion protein

Structural and Dynamic Properties of the Human Prion Protein.

Biophysical Characterization of Oligomerization and Fibrillization of the G131V Pathogenic Mutant of Human Prion Protein.

Aggregation of Prion Protein with Insertion Mutations is Proportional to the Number of Inserts

Prion propagation and molecular chaperones